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Many species of bacteria secrete natural products that inhibit the
growth or development of competing species. In turn, competitors
may develop or acquire resistance to antagonistic molecules. Few
studies have investigated the interplay of these countervailing
forces in direct competition between two species. We have used
an imaging mass spectrometry (IMS) approach to track metabolites
exchanged between Bacillus subtilis and Streptomyces sp. Mg1
cultured together. Surfactin is a cyclic lipopeptide produced by B.
subtilis that inhibits the formation of aerial hyphae by streptomy-
cetes. IMS analysis exposed an addition of 18 mass units to surfac-
tin in the agar proximal to Streptomyces sp. Mg1 but not other
streptomycetes tested. The spatially resolved change in the mass
of surfactin indicated hydrolysis of the molecule. We observed
that the aerial growth of Streptomyces sp. Mg1 was resistant to
inhibition by surfactin, which suggests that hydrolysis was a mech-
anism of resistance. To identify possible enzymes from Streptomy-
ces sp. Mg1 with surfactin hydrolase activity, we isolated secreted
proteins and identified candidates by mass spectrometry. We pu-
rified one candidate enzyme that hydrolyzed surfactin in vitro. We
tested the role of this enzyme in surfactin resistance by deleting
the corresponding gene from the S. Mg1 genome. We observed
that aerial growth by the ΔsfhA mutant strain was now sensitive
to surfactin. Our results identify an enzyme that hydrolyzes sur-
factin and confers resistance to aerial growth inhibition, which
demonstrates the effective use of an IMS approach to track natural
product modifications during interspecies competition.
antibiotic resistance | microbial ecology | secondary metabolism | surfactant
Competition among bacterial species involves the exchange ofnatural product metabolites, including antibiotics, signals,
and toxins (1–6). Natural products benefit producing bacteria
through signaling and inhibitory functions toward competitor
bacteria (7–9). However, many of these metabolites provide
a powerful selection for resistance to emerge within bacterial
communities. Recent surveys of microbial communities have
demonstrated the widespread nature of antibiotic resistance in
the microbial world (10–12). The prevalence of antibiotic pro-
ducing bacteria in the environment accords with the diverse re-
sistance mechanisms that detect and defuse a range of bioactive
natural products (reviewed in ref. 13). One of the hallmark forms
of antibiotic resistance is the enzymatic degradation or modifi-
cation of specific xenobiotic metabolites (14). For example,
β-lactamases hydrolyze penicillins, which block their cell wall
inhibitory activity and consequent lysis of the exposed cells
(reviewed in ref. 15). Enzymatic mechanisms of resistance are
not limited to antibiotics. Degradative enzymes that impact
competitive interactions also include those that degrade metab-
olites with signaling functions. For instance, quorum-quenching
activities, such as homoserine lactonases, degrade the quorum-
signaling compounds that regulate cell-density–dependent func-
tions in competing species (16–18). Enzymes that degrade or
modify natural products provide protection by blocking the an-
tagonistic and competitive functions. However, beyond antibiotic
resistance, relatively little is known about enzymatic trans-
formations of secreted metabolites that occur during competitive
interactions between species of bacteria.
This report focuses on an antagonistic function of the natural
product surfactin during bacterial competition between two soil
organisms and a mechanism of resistance toward surfactin.
Surfactin is a cyclic lipodepsipeptide that is secreted by species of
Bacillus and disrupts the growth and development of other
organisms (19–22). The microbial functions described for sur-
factin encompass its powerful surfactant activity, antibiotic and
antiviral activities, and a recently described paracrine signaling
function during biofilm development by B. subtilis (23–29). In
prior studies of competitive interactions between Streptomyces
coelicolor and B. subtilis, surfactin was found to inhibit strepto-
mycete development of aerial hyphae and spores (30, 31). De-
spite multiple examples of its antagonistic effects, mechanisms of
microbial resistance to surfactin have yet to be described. In-
stability of surfactin in soils has been reported, suggesting deg-
radation by microorganisms in the environment, but mechanisms
for the degradation of surfactin are unknown (32).
Surfactin acts primarily on cellular membranes to disrupt
membrane integrity (33). The micelle-forming properties of
surfactin, which complement the membrane active properties of
the molecule, may complicate the identification of a resistance
mechanism. The cyclized peptide moiety of surfactin folds into
a “horse saddle” structure that contributes to the exceptional
surfactant properties and stability of the molecule (34). The
surface activity and stability are in part due to incorporation of L-
and D-amino acids, which facilitate folding of the peptide to form
an amphipathic headgroup. The complete surfactin molecule
also includes a hydrophobic acyl chain, which varies in length,
with C13, C14, and C15 forms predominant (34, 35). Complete
surfactin monomers assemble into micelles at a low critical mi-
cellar concentration (CMC), enhancing the surfactant properties
of the molecules (36). The overall stability of surfactin most
likely arises from the combination of the folded peptide struc-
ture, the incorporation of D-amino acids, and the self-association
of the monomers. Evidence for limited proteolytic susceptibility
of surfactin was discovered in an in vitro study of purified V8
endoprotease from Staphylococcus aureus (37). Surfactin peptide
cleavage was minimal in these experiments, degrading ∼14% of
the total metabolite pool, despite extensive incubation with the
enzyme. Thus, the identity of enzymes that efficiently degrade
surfactin remains uncertain.
Here, we report the identification of a mechanism of surfac-
tin resistance from a soil actinomycete, Streptomyces sp. Mg1
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(S. Mg1), in a competitive interaction with B. subtilis. To follow
the fates of surfactin and other natural products in competition
with S. Mg1, a MALDI-TOF–based imaging mass spectrometry
(IMS) approach was used (31, 38, 39). IMS provided a method to
track in situ the secretion and modification of surfactin during
interspecies interactions. The IMS data suggested that S. Mg1
hydrolyzes surfactin. Specifically, we observed a spatially local-
ized +18 m/z mass change for surfactin as it diffused from col-
onies of B. subtilis toward colonies of competing S. Mg1. Several
species of Streptomyces were tested for sensitivity to surfactin-
induced balding. S. Mg1 was found to be the only species of
those tested that could form aerial hyphae in the presence of
surfactin. The detection of surfactin hydrolysis during in-
terspecies competition led to efficient identification and purifi-
cation of the hydrolyzing enzyme produced by S. Mg1. We
reasoned that this enzyme could provide a surfactin resistance
mechanism for S. Mg1, which was confirmed by deletion of the
gene encoding the surfactin hydrolase.
Results
Imaging Mass Spectrometry Reveals Surfactin Degradation. In
a survey of streptomycetes cultured with B. subtilis NCIB3610,
we observed that aerial growth and spore development were
disrupted to varying degrees for several species of Streptomyces
(Fig. S1). Based on our previous observation that surfactin
inhibits aerial development of S. coelicolor, which we describe as
a balding effect, we hypothesized a role for surfactin in these
competitive interactions (Fig. 1A) (30, 31). However, the relative
differences in growth, development, and metabolism of the two
organisms in coculture obscure the functions of individual
metabolites. As an approach to monitoring natural products,
including surfactin, during competitive interactions between
B. subtilis and streptomycetes, we used MALDI-imaging mass
spectrometry (IMS) (31, 40). B. subtilis and Streptomyces spp. are
commonly isolated from soils where they compete for resources
when they are actively growing. We focused on one species in
particular, Streptomyces sp. Mg1 (S. Mg1), because we isolated
the strain in parallel with strains of B. subtilis from a single
sample of soil in which the species may naturally compete (41).
We used IMS to monitor the production and fate of natural
product metabolites in the competitive interaction between B.
subtilis NCIB3610 and S. Mg1 (31, 40). Application of IMS en-
abled spatial tracking of metabolites in the mass range that we
surveyed, 500–3000 m/z. For surfactin, multiple ions are detected
as a result of its variable-length acyl chain (Fig. 1A). Individual
surfactin ions are separated by 14 mass units: m/z 1047 [C13 +
K]+, m/z 1061 [C14 + K]+, and m/z 1075 [C15 + K]+. This
typical pattern of surfactin ions was detected in the space be-
tween the B. subtilis colonies and S. Mg1 (Fig. 1B2). Near the S.
Mg1 colony, new ions could be identified from the spectra in the
same mass range as the surfactins. Curiously, we noted that with
increasing proximity to S. Mg1, the newly visible peaks in the
IMS spectra corresponded to each surfactin ion +18 m/z (Fig. 1
B3 and C). Progression through the sequence of images of Fig. 1
illustrates the spatial distribution of the new ions. Individual
mass spectra from selected positions in the coculture show an
increase in intensity of the new ions near S.Mg1 (surfactin +18 =
m/z 1093) concomitant with a decrease in the intensity of the
parent surfactin ion (m/z 1075). This observed pattern suggests
the +18m/z ions are surfactins undergoing hydrolysis by an activity
secreted from S.Mg1. To confirm the +18m/z ions were related to
the surfactin ions, and not unique metabolites secreted by S. Mg1,
we fragmented the ions by using tandem MS/MS. The resulting
patterns of b- and y-ion fragmentation for the +18 m/z ions were
Fig. 1. IMS of surfactin from B. subtilis 3610 with Streptomyces sp. Mg1. (A)
The structure of surfactin with the variable length acyl chain indicated in
brackets (kn), and the bond forming the lactone marked with an arrow. (B1)
Image of B. subtilis and S. Mg1 cultured for IMS (Materials and Methods).
S. Mg1 (vertical arrow) was inoculated as a streak of spores. B. subtilis (small
arrows, right) was inoculated in two spots to the right of S. Mg1. The images
(B2–B4) depict ions for C13-surfactin (m/z 1047, red; B2) and hydrolyzed (+18
m/z) C13-surfactin (m/z 1065, yellow; B3). An overlay of B1 and B2 illustrates
the relative spatial distribution of ions (B4), revealing surfactin hydrolysis
in proximity to the S. Mg1. (C) Single spectra from the imaging data of
a B. subtilis 3610 and S. Mg1. An increase in surfactin +18 m/z ion intensity
occurs with a corresponding reduction in the intact surfactin ion intensity.
The spectral window is limited to the range m/z 1070–1105 to highlight
representative C15-surfactin [M+K]
+ (m/z 1074.76) and hydrolyzed surfactin
ions [M+K+H2O]
+ (m/z 1092.81) in succession from near the Bacillus colony
(C1), at the midpoint between the colonies (C2), and near the S. Mg1 colony
(C3 and C4). Note: m/z 1078.72 is the hydrolyzed [M+K+H2O]+ ion of C14-
surfactin (m/z 1060.75).
Hoefler et al. PNAS | August 7, 2012 | vol. 109 | no. 32 | 13083
M
IC
RO
BI
O
LO
G
Y
CH
EM
IS
TR
Y
consistent with their identity as hydrolyzed C13, C14, and C15
surfactins (Fig. S2). Intriguingly, similar results were obtained from
IMS and tandem MS/MS analysis of plipastatin, a second lip-
opeptide synthesized by B. subtilis (Fig. S3). Surfactin and plipas-
tatin peptides are both macrolactones, but they differ in amino
acid composition and lipid chain length. The structural differences
between the molecules suggest that S. Mg1 secretes either a hy-
drolytic activity that cleaves both surfactin and plipastatin or
multiple activities that target the substrates specifically.
Aerial Development of Streptomyces sp. Mg1 Is Resistant to
Surfactin. Identification of hydrolyzed surfactin near the S. Mg1
colony suggested this streptomycete is resistant to surfactin. We
tested S. Mg1 and other streptomycetes for aerial growth in the
presence of the purified compound (Fig. 2). Surfactin spotted on
the center of a uniform lawn of bacteria caused areas of balding
with diameters of ∼1–3 cm, depending on the species. In addi-
tion to balding, some of the species tested were growth inhibited
at the site of surfactin deposition, in contrast to the diffuse area
of surfactin-induced balding. This report focuses solely on the
balding effect of surfactin. Direct application of surfactin failed
to block aerial development of S. Mg1 at concentrations that
inhibit aerial hyphae formation in all of the other strains tested
(Fig. 2). Based on the results of our imaging and culture assays,
we reasoned that the soil isolate S. Mg1 secretes an enzyme that
provides resistance to surfactin-induced balding through the
hydrolysis of surfactin.
Identification of a Putative Surfactin Hydrolase via Analysis of S. Mg1
Secreted Proteins. Suspecting an enzymatic mechanism of re-
sistance to surfactin, we predicted the enzyme responsible could
be identified from the agar media of a S. Mg1 culture plate. Agar
was collected from the area surrounding the streptomycete my-
celium, and soluble proteins were extracted and concentrated.
A collection of secreted proteins was detected by Coomassie
staining of an SDS/PAGE gel, and the proteins were identified
by tandem LC/MS/MS (Fig. S4A and Table S1). Many of the
proteins identified were annotated as degradative enzymes, in-
cluding proteases, lipases, and other hydrolases. When grouped
by annotated function, several of the identified proteins were
predicted to have hydrolytic activity on peptide or protein sub-
strates (Table 1). Highly similar orthologous sequences could
be identified for some candidates by using BLAST searches of
available Streptomyces spp. genomes. However, a candidate
protein that was annotated “secreted hydrolase” (gij254386602)
was notable for its sequence divergence from its closest relatives,
including those from nonsurfactin degrading species (Table S2).
We cloned this putative secreted hydrolase gene and other
candidate genes from S. Mg1 for recombinant expression, puri-
fication, and in vitro testing.
Expression and Purification of a Surfactin Hydrolase. A cloned copy
of the candidate hydrolase gene was expressed with a 6×-histi-
dine tag in Escherichia coli. We detected an ∼54-kDa band in
whole cell lysates of E. coli expressing the secreted hydrolase
gene. Assays of the cell lysates by MALDI-MS showed hydrolysis
of surfactin (Fig. S4). Because the protein was largely insoluble
in E. coli, affinity purification was carried out under denaturing
conditions on a Ni+-NTA resin. The purified, unfolded protein
was gradually refolded by stepwise removal of the denaturant
(Fig. S4B, lanes C1 and C2). In an in vitro assay, 320 ng of the
purified enzyme catalyzed rapid hydrolysis of 50 μM surfactin
in a 100-μL reaction over a period of 10–30 min (Fig. 3). Intact
surfactin ions (1029, 1043, 1057, 1065, and 1079 [M + Na]+)
diminished over the course of the reaction, whereas hydrolyzed
surfactin +18 m/z ions emerged (1047, 1061, 1075, 1083, 1097
[M + Na]+). A control reaction without the secreted hydrolase
showed no change in the spectrum of surfactin over a 2-h time
period (Fig. 3). Based on the in vitro enzyme activity, we conclude
that the enzyme functions as a surfactin hydrolase. We considered
the possibility that the enzyme could hydrolyze other lipopeptide
or macrolactone substrates. To test this possibility, we incubated
surfactin hydrolase with several lipopeptides and cyclic antibiotics
as well as iturin A, which is cyclized via a lactam instead of lactone
(Table 2 and Fig. S5). Surfactin and plipastatin were the only
substrates to be cleaved by the surfactin hydrolase in these assays.
Surfactin Hydrolase from S. Mg1 Cleaves the Ester That Forms the
Macrocycle of Surfactin. Analysis of the tandem mass spectral
data used to identify the surfactin +18 m/z ions suggested that
hydrolysis occurs at the ester of surfactin, but hydrolysis else-
where in the peptide could not be excluded (Fig. S2). To confirm
the site of hydrolysis, we prepared a sample of enzyme-hydro-
lyzed surfactin and determined the cleavage site by 2D NMR
(HSQC). Intact, cyclic surfactin shows a C3 (71.4 ppm)–H3 (5.06
ppm) correlation from the methine (C-H) adjacent to the ester
in the acyl chain that is clearly resolved from the other aliphatic
resonances (Fig. S6). Consistent with hydrolysis of the ester, this
correlation shifts upfield in both dimensions, C3 (67.0 ppm)–H3
(3.70 ppm), for the enzyme-treated surfactin. Together with the
tandem MS data for the ions near S. Mg1 (Fig. S2), these
observations support hydrolytic cleavage of the lactonizing ester,
which results in a linear surfactin +18 m/z product.
Surfactin Hydrolase Provides a Mechanism of Resistance to Surfactin-
Induced Balding of S. Mg1. Identification of the secreted hydrolase
enabled us to ask whether the enzyme confers resistance to
surfactin-induced balding. The gene encoding the surfactin hy-
drolase (denoted as sfhA) was deleted from the S. Mg1 genome
to obtain the ΔsfhA strain (PDS0366). When cultured in iso-
lation, the ΔsfhAmutant strain showed no apparent phenotype in
growth, sporulation, or pigmentation, which were similar to wild
type. However, the ΔsfhA strain was unable to hydrolyze
S. aizunensis
S. coelicolor
S. Mg1
S. anulatus
S. avermitilis
S. griseoflavus
S. pristinaespiralis
S. sviceus
DMSO Surfactin DMSO Surfactin
Fig. 2. S. Mg1 is resistant to the surfactin induced balding seen with several
Streptomyces spp. Streptomyces spp. were plated on mineral supplemented
MYM7 media as uniform density lawns and incubated at 30 °C until aerial
development was observed. Spotted in the center of each plate were either
DMSO as a control (Left and Left Center) or purified surfactin dissolved in
DMSO to 20 mg/mL (Right Center and Right). Surfactin sensitivity is seen as
a bald patch in the plate center. Only S. Mg1 develops aerial hyphae with
surfactin. Species are as labeled and listed in Table S3.
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surfactin as detected by IMS (Fig. 4A and Fig. S4). We sought to
determine whether the ΔsfhA strain is sensitive to surfactin, and
whether the linearized surfactin retains inhibitory activity toward
aerial development of streptomycetes. Hydrolyzed surfactin was
obtained in a reaction with surfactin hydrolase until no cyclized
form was detected by MALDI-MS (estimated ≥95% hydro-
lyzed). To confirm that in vitro hydrolysis disrupted the aerial
inhibitory activity, we applied equal amounts of intact and
linearized compound to the wild-type strain of S. avermitilis,
which is highly sensitive to surfactin induced balding. The S.
avermitilis formed aerial hyphae in the presence of hydrolyzed
surfactin but not intact surfactin (Fig. 4B). Some residual effects
of the hydrolyzed surfactin were observed with this strain, which
may reflect a low level of activity from the linear surfactin or may
be due to a small amount of cyclic surfactin remaining (estimated
≤5%). Consistent with previous observations, the wild-type
S.Mg1 showed no balding sensitivity to either the intact surfactin
or the enzyme-hydrolyzed surfactin. By contrast, the S. Mg1
ΔsfhA mutant strain was sensitive to intact surfactin, which was
detected as an area of balding on the lawn of sporulating bacteria
(Fig. 4B). This unprecedented balding of S. Mg1 upon treatment
with purified surfactin indicates that resistance was abolished by
deletion of the enzyme. A cloned copy of the sfhA gene com-
plemented the deletion when integrated in single copy into the
genome of the mutant strain, confirming the specific function of
the hydrolase in resistance to balding (Fig. 4 and Fig. S4). Ac-
cordingly, we observed no balding activity upon treatment of any
S. Mg1 strain with previously hydrolyzed surfactin, indicating
that only the cyclic form blocks aerial development.
Discussion
Enzymatic mechanisms of antibiotic resistance have been de-
scribed as “the apogee of the bacterial antibiotic counter-
measures” (13). Enzymes with high specificity for xenobiotic
substrates provide resistance to a range of antibiotics and may
acquire mutations that expand their substrate range (42). The
natural functions of these enzymes are found within microbial
communities, which function as reservoirs of antibiotic resistance
within diverse environments, including the human microflora
and soils (10, 11). Here, we have used an IMS strategy to identify
an enzymatic activity that hydrolyzes surfactin, which provides
S. Mg1 with a mechanism of resistance to the balding effects of
the molecule. Surfactin from B. subtilis has been investigated
extensively for its multiple functions, potential medical and in-
dustrial applications, and as a model for natural product enzy-
mology (21, 43, 44). We focused on the antagonistic function of
surfactin in blocking development of aerial filaments by strep-
tomycetes. The recognition of surfactin hydrolysis by IMS led
to the targeted purification and characterization of the active
hydrolase. We found that the surfactin hydrolase secreted by
S. Mg1 efficiently degrades surfactin from B. subtilis. The sfhA
gene was then deleted from the S.Mg1 genome, which resulted in
the strain converting from surfactin resistant to surfactin sensitive.
Based on sequence comparisons to known enzymes, the sur-
factin hydrolase is a secreted enzyme of the tripeptidyl amino-
peptidase (TAP) hydrolase family (45). The protein sequence of
the surfactin hydrolase contains 499 amino acids with a predicted
molecular mass of ∼54 kDa. The conserved domains within the
protein include an α/β hydrolase_1 folded domain (pfam00561,
E value 5.84 × 10−6), characteristic of a wide range of hydro-
lases from many species. A second domain near the C-terminal
end of the protein is of the α/β hydrolase_4 type found in
TAP enzymes from Streptomyces lividans (pfam08386, E value
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Fig. 3. MALDI-TOF assay reveals surfactin hydrolysis by the purified se-
creted hydrolase. MALDI-TOF mass spectra of surfactin ions following re-
action with the purified secreted hydrolase. The reactions were quenched
with acetone at the indicated times. Them/z 1020–1120 spectra show results
of reactions with enzyme quenched at 0 (Top) and 30 min (Middle) and
without enzyme at 120 min (Bottom). After 30 min of incubation with en-
zyme, the majority of surfactin is hydrolyzed to (surfactin +18 m/z).
Table 1. Secreted hydrolases from Streptomyces Mg1
Protein annotation NCBI gi identifier Protein molecular mass, Da
Secreted tripeptidylaminopeptidase 254384290 58089.9
Peptidase S8 and S53 subtilisin kexin sedolisin 254381890 51429.4
Secreted hydrolase 254386602 53901.7
Serine protease 254382793 114805.7
Trypsinogen 254387105 26540.7
Streptogrisin-B 254387168 29877.1
Phospholipase D 254384004 35716.5
Leupeptin-inactivating enzyme 1 254382420 45319.5
Secreted proteins from the media surrounding an S. Mg1 colony were identified by LC/MS/MS. The proteins
were grouped by their annotated function. Proteins with predicted hydrolytic activity on peptide or protein-like
substrates are shown. The surfactin hydrolase is highlighted in bold.
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1.10 × 10−9) and belongs to the esterase-lipase superfamily based
on the conserved catalytic core. Despite the presence of genes
encoding similar hydrolases, we did not detect surfactin hydro-
lysis activity from other Streptomyces species tested. The S. Mg1
enzyme may have some intriguing structural differences that
confer substrate specificity for surfactin but also show di-
minished hydrolysis of plipastatin and possibly other lip-
opeptides. Together with our experimental results, the primary
sequence information for the enzyme supports its observed
function as a lipopeptide hydrolase variant of a larger family of
secreted hydrolases.
Surfactin belongs to the lipodepsipeptide class of natural
products, which includes antibiotics such as daptomycin and
ADEPs (46, 47). Although the surfactin hydrolase had activity
against the lipopeptide plipastatin in addition to surfactin, other
compounds tested were not substrates for the enzyme. The ability
of the enzyme to hydrolyze two structurally different substrates
suggests that one or a few random mutations in the surfactin
hydrolase gene may produce an enzyme permissive for hydrolysis
of daptomycin or other lipopeptides. Studies on enzyme pro-
miscuity toward substrates such as plipastatin and daptomycin, as
well as structural characterization of the substrate-binding do-
main, will be of interest. This report demonstrates that bacterial
competition and IMS is a useful tool for discovery of activities
that degrade many types of natural products. In particular, the
imaging strategy described is a unique method for discovering and
understanding antibiotic resistance and could be applied to
a range of microbial communities and interactions.
Materials and Methods
Bacterial Strains and Media. The strains used for this study were B. subtilis
3610 (PDS0066), S. Mg1 wild type (PSK0558), ΔsfhA (PDS0366), and ΔsfhA,
sfhA ApR (PDS0424). Other B. subtilis and Streptomyces spp. are as listed in SI
Materials and Methods. Spore suspensions of Streptomyces spp. were pre-
pared by using standard procedures (48) and used for the described plating
experiments. Bacto media reagents were used unless otherwise indicated.
Media for Streptomyces growth [Glucose, Yeast-Extract, Malt-Extract (GYM)
and Malt-extract Yeast-extract Maltose (MYM)] and coculture conditions are
described in SI Materials and Methods. Surfactin, amino acids, thiamine-HCl,
Mops, and Universal Matrix were purchased from Sigma-Aldrich along with
other chemical reagents, unless otherwise noted. All solvents used were
HPLC grade. The E. coli WM3780 strain was used as the donor strain for
conjugation with S. Mg1 (49). E. coli XL10-Gold and XL1-Blue strains (Stra-
tagene) were used for cloning, and the E. coli Rosetta (DE3) strain (Novagen)
was used for protein overexpression. For long-term storage, bacterial strains
were preserved cryogenically at −80 °C in water (Streptomyces spp. spores)
or 20% (vol/vol) glycerol (B. subtilis and E. coli). The primers used in this
study are listed in Table S4.
Cultures of Streptomyces spp. with B. subtilis or Purified Surfactin. Coculture
experiments were generally carried out as previously described (30) (SI
Materials and Methods). The spore density for plating was varied between
104 and 106 spores per 100-mm plate to obtain consistent and even aerial
development across the plate. Buffered GYM was the preferred media for
coculture, but supplemented MYM was used for S. pristinaespiralis. Mineral
supplemented, bufferedMYMwas used for surfactin tests, except in the case of
S. aizunensis where supplemented, buffered GYM was used. Purified surfactin
was dissolved in DMSO at a concentration of 20 mg/mL. Hydrolyzed surfactin
was prepared enzymatically, as described for the NMR analysis (SI Materials and
Methods), and redissolved after desalting to a concentration of 20 mg/mL in
DMSO. Aliquots (5 μL) of surfactin, hydrolyzed surfactin, or DMSO as a negative
control were added to the center of each plate. The plates were incubated at
30 °C as described for cocultures until aerial hyphae were observed.
MALDI IMS. The format for coculture of B. subtilis with S. Mg1 (SI Materials
and Methods) was altered slightly to be more suitable for the MALDI im-
aging experiments. A spore suspension was inoculated in a dense format as
either a line across the plate, or in evenly spaced 6-μL drops across the plate
(Fig. S3). B. subtilis was inoculated (2 μL of an LB overnight culture) adjacent
to the S. Mg1. After incubation on thin agar plates (SI Materials and
Methods), the agar layer was separated from the plates and used for MALDI
imaging. Cultures were prepared for MALDI imaging by transferring the thin
agar sections to a Bruker MSP 96 anchor plate. Universal Matrix was
Table 2. Surfactin hydrolase specificity for surfactin and
plipastatin compared with other potential lipopeptide and
macrocyclic substrates
Compound Hydrolysis*
Surfactin +
Plipastatin ±
Iturin A −
Daptomycin −
A54145D −
Nystatin −
Amphomycin −
Amphotericin B −
Erythromycin −
CDA† −
The purified hydrolase was incubated with the metabolites listed for 30
min. +, ∼95% hydrolysis; ±, some hydrolysis; −, no hydrolysis detected under
conditions used.
*See Fig. S5 for corresponding mass spectra.
†Calcium-dependent antibiotic.
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Fig. 4. The ΔsfhAmutant strain does not hydrolyze surfactin and is sensitive to
surfactin-induced balding. (A) Purified surfactin (70 μg) was placed on a filter
between the wild-type (Upper) and ΔsfhA (Lower) strains. The IMS depicts hy-
drolysis of the m/z 1074 ion of surfactin (lavender) to the m/z 1092 (+18 m/z)
form (yellow) by the wild-type strain but not the ΔsfhA strain. (B) Untreated
surfactin (Upper) or hydrolyzed surfactin (Lower) (∼100 μg)was applied to lawns
of S. avermitilis, wild-type S. Mg1, the ΔsfhA, and the complemented (ΔsfhA +
sfhA) strains. After the onset of aerial development, “bald” patches due to
surfactin are on the plates. S. avermitilis is highly sensitive to cyclized surfactin
but not to enzymatically hydrolyzed surfactin.Wild-type S. Mg1 produces aerial
hyphae in the presenceof both cyclized andhydrolyzed surfactin. Aerial hyphae
are blocked by surfactin, which is seen as a bald patch on the ΔsfhA mutant
strain of S. Mg1. The genetically complemented mutant (ΔsfhA + sfhA) grows
aerial hyphae similar to wild type when treated with surfactin. When hydro-
lyzed by the purified enzyme, surfactin does not block aerial hyphae.
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deposited evenly over the agar by using a 53-μm test sieve. The agar with
matrix was then dried in a 40 °C oven for 1–3 h until desiccated. The sample
was dusted with a nitrogen stream and then inserted into a Microflex Bruker
Daltonics mass spectrometer for data collection. The data were filtered
manually by selecting ions of interest from the average spectrum or from
individual spectra and is presented without normalization.
For IMS of wild type and ΔsfhA S. Mg1 activity, 1 μL of each spore stock
(109 spores per mL; PSK0558 and PDS0366) were spotted 1.5 cm apart on
a 10-mL GYM (2% agar) plate. Once dry, 3 μL of 23 mg/mL surfactin (69 μg)
was placed on a filter disk between the inoculated spots. The plate was
sealed with parafilm and incubated upside down at 30 °C for 48 h. Then, the
sample was cut out of the plate and transferred to the MALDI target plate.
The filter disk was removed, Universal Matrix was applied through a 53-μm
sieve, and the sample was dehydrated at 37 °C. After the excess matrix was
removed, IMS was performed in linear mode by using a Bruker Autoflex
Speed at 600-μm resolution after calibrating to the Peptide Calibration
Standard (Bruker 20619). Data were acquired from 500 to 1500 Da at 952
measurement points. The images were acquired by using a raster program as
described (31). Extracted ion images were prepared by using TissueView 1.1
(AB SCIEX) and colored in Adobe Photoshop CS3.
Enzyme Activity Assays. Surfactin (50 μM, mixture of lipopeptides) and other
antibiotics assayed (50 μM each) were reacted with purified hydrolase (320
ng) at ambient temperature in 100-μL assay buffer (50 mM Tris·HCl at pH
8.0, 150 mM NaCl, and 1 mM DTT). Reactions were quenched with 500 μL of
acetone. Surfactin samples were quenched at time points of 0, 10, 20, 40,
60, and 120 min. A saturated solution of 20–30 mg/mL Universal Matrix
dissolved in 1:1 acetonitrile:water with 0.2% TFA (1.0 μL) was cospotted on
a MALDI plate with the quenched reaction mixture (1.0 μL), and MS1
spectra were collected on a Shimadzu Axima-CFR MALDI-TOF mass spec-
trometer. The extent of surfactin hydrolysis was determined (semi-
quantitatively) by comparing the ratios of intact surfactin ion ([M+Na]+) to
hydrolyzed surfactin ion ([M+Na+H2O]
+) for representative ions at the dif-
ferent time points.
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